Fetal Bovine Serum Market Size

Fetal Bovine Serum Market Size

Fetal Bovine Serum Market size was valued to be USD 1.1 billion in 2022 and is expected to reach USD 2.5 billion in 2032 with a CAGR of 8.1% till 2032 driven by the expanding scope of research and development within the pharmaceutical and biotechnological sectors.

This expansion is paralleled by the increasing occurrence of chronic diseases, where the utilization of fetal bovine serum in both diagnosis and treatment has gained notable prominence. Also, fetal bovine serum, due to its rich nutrient composition, is notably integrated into cell culture processes, aiding cell growth and fostering research endeavors. This symbiotic relationship between research demands and disease prevalence has led to a notable industry upswing in the usage of fetal bovine serum within these critical industries. Moreover, high demand of sera in among end-users including academic institutes for drug development and cell culture media.

Fetal bovine serum, also known as fetal calf serum, is a blood-derived product obtained from the blood of fetal bovine (cow) foetuses. It is rich in various growth factors, hormones, and other nutrients, making it an ideal supplement to promote the progress and proliferation of many types of animal cells.